BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23283436)

  • 21. Mesenchymal stem cells: mechanisms of inflammation.
    Singer NG; Caplan AI
    Annu Rev Pathol; 2011; 6():457-78. PubMed ID: 21073342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult stem cell transplantation in autoimmune disease.
    Tyndall A; Gratwohl A
    Curr Opin Hematol; 2009 Jul; 16(4):285-91. PubMed ID: 19465851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mesenchymal stem/stroma cells : Therapeutic potential in the treatment of autoimmune diseases].
    Schäfer R; Daikeler T
    Z Rheumatol; 2016 Oct; 75(8):786-794. PubMed ID: 27481118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders.
    Bernardo ME; Fibbe WE
    Ann N Y Acad Sci; 2012 Aug; 1266():107-17. PubMed ID: 22901262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases.
    Tyndall A
    Pediatr Res; 2012 Apr; 71(4 Pt 2):433-8. PubMed ID: 22358068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.
    Mannon PJ
    Expert Opin Biol Ther; 2011 Sep; 11(9):1249-56. PubMed ID: 21787241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of mesenchymal stem cell therapy.
    Dazzi F; Horwood NJ
    Curr Opin Oncol; 2007 Nov; 19(6):650-5. PubMed ID: 17906466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation.
    Gieseke F; Kruchen A; Tzaribachev N; Bentzien F; Dominici M; Müller I
    Eur J Immunol; 2013 Oct; 43(10):2741-9. PubMed ID: 23817958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair.
    Dhingra S; Huang XP; Li RK
    Trends Cardiovasc Med; 2010 Nov; 20(8):263-8. PubMed ID: 22433652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of mesenchymal stem cells derived from gingival tissue and periodontal ligament in different incubation conditions.
    Yang H; Gao LN; An Y; Hu CH; Jin F; Zhou J; Jin Y; Chen FM
    Biomaterials; 2013 Sep; 34(29):7033-47. PubMed ID: 23768902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles.
    Fierabracci A; Del Fattore A; Luciano R; Muraca M; Teti A; Muraca M
    Cell Transplant; 2015; 24(2):133-49. PubMed ID: 24268069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunologic and oncological safety of autologous and allogenic mesenchymal bone marrow stromal cells].
    Lazebnik LB; Sagynbaeva VÉ
    Eksp Klin Gastroenterol; 2014; (7):67-71. PubMed ID: 25842409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations.
    Wang J; Liao L; Wang S; Tan J
    Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies.
    Cipriani P; Ruscitti P; Di Benedetto P; Carubbi F; Liakouli V; Berardicurti O; Ciccia F; Triolo G; Giacomelli R
    Cytotherapy; 2015 Jul; 17(7):832-49. PubMed ID: 25680301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for mesenchymal stem cells in the control of graft-versus-host disease.
    Cohen JL; Sudres M
    Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell trials for pulmonary diseases.
    Antunes MA; Laffey JG; Pelosi P; Rocco PR
    J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue?
    Carrion FA; Figueroa FE
    Stem Cell Res Ther; 2011 May; 2(3):23. PubMed ID: 21586107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.